Home > Financial Ratios > LYKA LABS

LYKA LABS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 17.46-15.17-80.40385.973,765.48

What is the latest Core EBITDA Growth ratio of LYKA LABS ?

The latest Core EBITDA Growth ratio of LYKA LABS is 17.46 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202517.46
Mar2024-15.17
Mar2023-80.40
Mar2022385.97
Mar20213,765.48

How is Core EBITDA Growth of LYKA LABS Trending?

Years Core EBITDA Growth % Change
Mar2025 17.46
Positive
Mar2024 -15.17
Negative
Mar2023 -80.4
Negative
Mar2022 385.97
-89.75
Mar2021 3765.48 -

Other Financial Ratios of LYKA LABS


Compare Core EBITDA Growth ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹276.2 Cr 4% -12.6% -54.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,513.0 Cr -0.1% 3.4% -0.1% Stock Analytics
DIVIS LABORATORIES ₹170,614.0 Cr 1.6% -2.5% 8.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,245.0 Cr 0.8% -0.9% 13.5% Stock Analytics
CIPLA ₹122,555.0 Cr 1.3% -0.6% 3.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,803.0 Cr 1% 3.7% 2.7% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

4%

-12.6%

-54.4%

SENSEX

-0.5%

1%

4.6%


You may also like the below Video Courses